Search Page
Save citations to file
Email citations
Email address has not been verified. Go to
My NCBI account settings
to confirm your email and then refresh this page.
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
My Custom Filters
Edit custom filtersResults by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Real-world outcomes of brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma: a CIBMTR analysis.
Blood Adv. 2025 Oct 28;9(20):5382-5396. doi: 10.1182/bloodadvances.2024015014.
Blood Adv. 2025.
PMID: 40706035
Free PMC article.
Real-world and clinical trial outcomes in large B-cell lymphoma with axicabtagene ciloleucel across race and ethnicity.
Locke FL, Siddiqi T, Jacobson CA, Ghobadi A, Ahmed S, Miklos DB, Perales MA, Munoz J, Fingrut WB, Pennisi M, Gauthier J, Shadman M, Gowda L, Mirza AS, Abid MB, Hong S, Majhail NS, Kharfan-Dabaja MA, Khurana A, Badar T, Lin Y, Bennani NN, Herr MM, Hu ZH, Wang HL, Baer A, Baro E, Miao H, Spooner C, Xu H, Pasquini MC.
Locke FL, et al.
Blood. 2024 Jun 27;143(26):2722-2734. doi: 10.1182/blood.2023023447.
Blood. 2024.
PMID: 38635762
Free PMC article.
Item in Clipboard
Real-world characteristics, treatment patterns, and outcomes of patients with 2 or more LOTs for CLL/SLL in the United States.
Davids MS, Ambrose J, de Nigris E, Prescott J, Leng S, Farooqui MZH, Gandra SR, Zettler CM, Fernandes LL, Wang CK, Shadman M.
Davids MS, et al.
Blood Neoplasia. 2024 Oct 14;2(1):100047. doi: 10.1016/j.bneo.2024.100047. eCollection 2025 Feb.
Blood Neoplasia. 2024.
PMID: 40546723
Free PMC article.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.